BIO KEY INTERNATIONAL INC

BKYI

Latest QuantConomy context for BKYI: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class

stock

Primary venue

NASDAQ

Recent signals

SEC filings

Asset profile

QuantConomy has a structured record for BKYI. More descriptive asset metadata will appear here when the platform record includes it.

Latest signal rows

Recent signals for BKYI

Scored rows are pulled from the same signal API used by the digests.

Signal	Direction	Score	Observed	Reason
corporate event accountant change	neutral	70	Jul 9, 09:00 PM	BKYI filed 8-K: Accountant Change - 1 material event - [strong neutral signal]
corporate event reg fd disclosure	neutral	70	Jul 7, 12:50 PM	BKYI filed 8-K: Regulation FD Disclosure - 1 material event - [strong neutral signal]
fundamental gross profit change	very bullish	76	Jun 12, 12:00 AM	BKYI (FY 2025, gross profit): grew 283.0% ($1.19M → $4.56M). [sequential period basis, very bullish signal]

FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.

Market	Exchange	Source	Asset record
BKYI	NASDAQ	alpaca	BIO-key International, Inc. Common Stock
BKYI	NASDAQ	fmp	BIO-key International, Inc.
BKYI	NASDAQ	alphavantage	Bio-Key International Inc

Buys, last 90d

Sells, last 90d

Rows

Date	Insider	Role	Type	Shares	Price	Value	Filing
Jun 30, 2026	Sullivan James David	Chief Legal Officer	grant	250	$3.83	$958	4 on EDGAR
Dec 31, 2025	LACOUS MIRA K	Chief Technology Officer	grant	2,500	$0.46	$1,150	4 on EDGAR
Dec 31, 2025	Sullivan James David	Chief Legal Officer	grant	2,500	$0.46	$1,150	4 on EDGAR
Dec 31, 2025	DEPASQUALE MICHAEL W	Chief Executive Officer	grant	2,500	$0.46	$1,150	4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.